reported that plasma IGFBP2 levels in PDAC patients were significantly higher than those in patients with chronic pancreatitis, adenitis, or healthy individuals, and this elevation was associated with poor overall survival (32). This evidence concerns the gene IGFBP2 and chronic pancreatitis.